Kun Ma Selected Research

glaucocalyxin A

1/2022	Corrigendum to Glaucocalyxin A suppresses inflammatory responses and induces apoptosis in TNF-a-induced human rheumatoid arthritis via modulation of the STAT3 pathway [Chem. Biol. Interact. 2021 May 25; 341 109451].
5/2021	Glaucocalyxin A suppresses inflammatory responses and induces apoptosis in TNF-a-induced human rheumatoid arthritis via modulation of the STAT3 pathway.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Kun Ma Research Topics

Disease

37	Neoplasms (Cancer) 09/2022 - 07/2011
15	Infertility (Sterility) 07/2022 - 09/2011
9	Osteosarcoma (Osteogenic Sarcoma) 01/2022 - 07/2016
7	Neoplasm Metastasis (Metastasis) 01/2022 - 12/2017
5	Pain (Aches) 12/2017 - 08/2006
3	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 09/2022 - 01/2022
3	Rheumatoid Arthritis 01/2022 - 05/2021
3	Breast Neoplasms (Breast Cancer) 01/2022 - 01/2017
3	Body Weight (Weight, Body) 01/2022 - 08/2003
3	Inflammation (Inflammations) 01/2022 - 01/2020
3	Carcinogenesis 11/2020 - 01/2019
3	Type 2 Diabetes Mellitus (MODY) 01/2020 - 05/2013
3	Insulin Resistance 01/2020 - 05/2013
3	Pelvic Inflammatory Disease (Pelvic Inflammatory Diseases) 10/2019 - 04/2017
3	Wounds and Injuries (Trauma) 01/2019 - 01/2017
2	Infections 06/2022 - 04/2020
2	Diabetes Mellitus 01/2022 - 06/2002
2	Dehydration (Water Stress) 01/2021 - 11/2019
2	Hepatocellular Carcinoma (Hepatoma) 12/2020 - 01/2020
2	Communicable Diseases (Infectious Diseases) 10/2019 - 09/2014
2	Polycystic Ovary Syndrome (Syndrome, Stein-Leventhal) 03/2019 - 12/2017
2	Sleep Initiation and Maintenance Disorders (Insomnia) 12/2017 - 10/2014
2	Dysmenorrhea (Menstrual Pain) 12/2017 - 10/2015
2	Uterine Hemorrhage (Uterine Bleeding) 12/2017 - 03/2014
2	Myocardial Infarction 10/2006 - 08/2006
2	Muscular Atrophy (Muscle Atrophy) 09/2006 - 08/2003
2	Atrophy 09/2006 - 08/2003
1	Cerebral Infarction 02/2022
1	Starvation 01/2022
1	Type 1 Diabetes Mellitus (Autoimmune Diabetes) 01/2022
1	Delirium 01/2022
1	Hypotension (Low Blood Pressure) 01/2022
1	Pathologic Processes 01/2022

Drug/Important Bio-Agent (IBA)

12	Pharmaceutical PreparationsIBA 09/2022 - 04/2013
6	bushen huoxueIBA 06/2021 - 10/2015
4	Thioredoxin Reductase 1IBA 04/2022 - 10/2021
4	Dexamethasone (Maxidex)FDA LinkGeneric 01/2021 - 08/2003
4	Therapeutic UsesIBA 01/2021 - 08/2006
4	Insulin (Novolin)FDA Link 01/2020 - 06/2002
3	Reactive Oxygen Species (Oxygen Radicals)IBA 02/2022 - 12/2018
3	Hormones (Hormone)IBA 01/2022 - 09/2011
3	Glucose (Dextrose)FDA LinkGeneric 01/2022 - 05/2013
3	GlucocorticoidsIBA 01/2021 - 08/2003
3	Proteins (Proteins, Gene)FDA Link 12/2019 - 03/2012
3	Silicon Dioxide (Silica)FDA LinkGeneric 11/2019 - 10/2013
3	Folic Acid (Vitamin M)FDA LinkGeneric 08/2018 - 10/2013
2	Sorafenib (BAY 43-9006)FDA Link 09/2022 - 06/2022
2	Hyaluronic Acid (Hyaluronan)IBA 06/2022 - 11/2019
2	AlkaloidsIBA 04/2022 - 05/2021
2	Facilitative Glucose Transport Proteins (Glucose Transporter)IBA 02/2022 - 01/2022
2	EnzymesIBA 02/2022 - 01/2017
2	Kelch-Like ECH-Associated Protein 1IBA 02/2022 - 01/2022
2	glaucocalyxin AIBA 01/2022 - 05/2021
2	PeriostinIBA 01/2022 - 11/2020
2	gamabufotalinIBA 01/2022 - 11/2020
2	NucleotidesIBA 01/2022 - 01/2020
2	ErbB Receptors (EGF Receptor)IBA 01/2022 - 09/2017
2	Small Interfering RNA (siRNA)IBA 01/2022 - 01/2020
2	CytokinesIBA 11/2021 - 05/2021
2	DNA (Deoxyribonucleic Acid)IBA 12/2020 - 01/2017
2	Vitamin D FDA LinkGeneric 01/2020 - 04/2019
2	ClathrinIBA 11/2019 - 08/2018
2	Tumor Biomarkers (Tumor Markers)IBA 04/2019 - 09/2017
2	ProlactinIBA 03/2019 - 12/2017
2	cinobufaginIBA 01/2019 - 07/2016
2	Cadherins (E-Cadherin)IBA 12/2018 - 12/2017
2	Anti-Bacterial Agents (Antibiotics)IBA 12/2018 - 04/2017
2	HydrogelsIBA 11/2018 - 01/2014
2	Focal Adhesion Protein-Tyrosine KinasesIBA 11/2018 - 01/2017
2	LipidsIBA 08/2018 - 01/2017
2	AlginatesIBA 08/2013 - 10/2012
2	musconeIBA 10/2006 - 08/2006
2	MyostatinIBA 09/2006 - 08/2003
1	Clomiphene (Clomifene)FDA LinkGeneric 07/2022
1	AcidsIBA 06/2022
1	FertilizersIBA 06/2022
1	erastinIBA 04/2022
1	Thioredoxin-Disulfide ReductaseIBA 04/2022
1	SelenocysteineIBA 04/2022
1	piperlongumineIBA 04/2022
1	plumbaginIBA 02/2022
1	6-Aminonicotinamide (6 Aminonicotinamide)IBA 02/2022
1	BAY-876IBA 02/2022
1	Glucosephosphate Dehydrogenase (Glucose 6 Phosphate Dehydrogenase)IBA 02/2022
1	Phosphatidylinositols (Phosphatidylinositol)IBA 02/2022
1	3-glucopyranosyloxybutanolideIBA 01/2022
1	shikoninIBA 01/2022
1	2- cyclohexylidenhydrazo- 4- phenyl- thiazoleIBA 01/2022
1	Biomarkers (Surrogate Marker)IBA 01/2022
1	NADP (NADPH)IBA 01/2022
1	cucurbitacin BIBA 01/2022
1	Pancreatitis-Associated ProteinsIBA 01/2022

Therapy/Procedure

24	Therapeutics 09/2022 - 01/2014
18	Chinese Traditional Medicine (Traditional Chinese Medicine) 06/2021 - 06/2005
7	Drug Therapy (Chemotherapy) 01/2022 - 12/2012
3	Photothermal Therapy 01/2022 - 12/2019
2	Aftercare (After-Treatment) 09/2017 - 08/2013
2	Intraperitoneal Injections 08/2015 - 08/2006
1	Intravenous Injections 01/2022
1	Intravenous Infusions 01/2022